AKBA logoAKBA
Akebia Therapeutics Inc.

20,827
Loading...
Loading...
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
181

Frequently Asked Questions

What is Market Cap of Akebia Therapeutics Inc.?
What is the 52-week high for Akebia Therapeutics Inc.?
What is the 52-week low for Akebia Therapeutics Inc.?
What is Akebia Therapeutics Inc. stock price today?
What was Akebia Therapeutics Inc. stock price yesterday?
What is the PE ratio of Akebia Therapeutics Inc.?
What is the Price-to-Book ratio of Akebia Therapeutics Inc.?
What is the 50-day moving average of Akebia Therapeutics Inc.?
How many employess does Akebia Therapeutics Inc. has?

Latest AKBA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.